Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity
- PMID: 50294
- DOI: 10.1002/ijc.2910160204
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity
Abstract
Lymphoid cells from many normal mice of a variety of inbred strains were found to have reactivity, in a 51Cr release cytotoxicity assay, against several syngeneic and allogeneic tumors. Very high reactivity was seen with effector cells from athymic nude mice, which was consistent with other evidence that the reactivity was not T-cell dependent. Target cells susceptible to lysis included tumors induced by oncogenic type-C viruses but also tumors induced by other means and expressing endogenous type-C viruses. The levels of natural reactivity were influenced by age, with highest cytotoxicity produced by cells from 5- to 8-week-old mice. Lymph-node cells, spleen cells, peritoneal exudate cells and peripheral blood lymphocytes all had cytotoxic reactivity. The specificity of the reactions was analyzed in detail by ana inhibition assay. Evidence was obtained for natural reactivty against several different antigens, each apparently associated with expression of murine endogenous type-C viruses.
Similar articles
-
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.Int J Cancer. 1975 Aug 15;16(2):230-9. doi: 10.1002/ijc.2910160205. Int J Cancer. 1975. PMID: 1080480
-
Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.Int J Cancer. 1977 Apr 15;19(4):555-64. doi: 10.1002/ijc.2910190417. Int J Cancer. 1977. PMID: 844921
-
Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.Cancer Res. 1976 Feb;36(2 pt 2):615-21. Cancer Res. 1976. PMID: 56223
-
The rapid elimination of allogeneic lymphocytes: relationship to established mechanisms of immunity and to lymphocyte traffic.Immunol Rev. 1983;73:87-113. doi: 10.1111/j.1600-065x.1983.tb01080.x. Immunol Rev. 1983. PMID: 6350161 Review.
-
Host immune response to virus-induced tumors. Some recent concepts.Prog Exp Tumor Res. 1974;19:23-36. doi: 10.1159/000395846. Prog Exp Tumor Res. 1974. PMID: 4373781 Review. No abstract available.
Cited by
-
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.Cancer Immunol Immunother. 2017 Feb;66(2):233-245. doi: 10.1007/s00262-016-1882-x. Epub 2016 Aug 16. Cancer Immunol Immunother. 2017. PMID: 27530271 Free PMC article. Review.
-
Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance.Cancers (Basel). 2020 Jun 12;12(6):1553. doi: 10.3390/cancers12061553. Cancers (Basel). 2020. PMID: 32545516 Free PMC article. Review.
-
Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas.Cancers (Basel). 2023 Dec 8;15(24):5760. doi: 10.3390/cancers15245760. Cancers (Basel). 2023. PMID: 38136307 Free PMC article. Review.
-
Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics.Antibodies (Basel). 2021 Mar 30;10(2):13. doi: 10.3390/antib10020013. Antibodies (Basel). 2021. PMID: 33808165 Free PMC article. Review.
-
Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.Cancer Immunol Immunother. 1990;32(3):154-60. doi: 10.1007/BF01771450. Cancer Immunol Immunother. 1990. PMID: 2126987 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources